Ergotrics
Timeline
27 events since 2014Board
Capital
Filings
Financial
Establishments
Address
2014201620182020202220242026
Deadline for the 2026 accounts: 31-07-2027
2026
Registered in the Peppol Directory Reachable for e-invoices through 0208:0506642480
1 director appointed, 1 resignation, 2 reappointmentsReappointments: Neuromedics BV and Martha1996 BV · Permanent representatives: Paul Depauw and Inge Bruynooghe · Appointment: Jan Vliegen · General meeting of 26-06-20269 points ▸
- General meeting, 26-06-2026
- Director reappointment, Neuromedics BV
- Permanent representative, Paul Depauw
- Director reappointment, Martha1996 BV
- Permanent representative, Inge Bruynooghe
- Director appointment, Jan Vliegen
- General meeting, 25-06-2026
- Director resignation, Filip Tanghe
- Director discharge, Filip Tanghe
Annual accounts 2025 filed NBBabbreviated format · 30 days before the deadline
2025
Annual accounts 2024 filed PDFmicro format · 28 days before the deadline
2024
Annual accounts 2023 filed PDFmicro format · 27 days before the deadline
2023
Annual accounts 2022 filed PDFmicro format · 31 days before the deadline
2022
Weakest financial year net -€543,713 The net result drops to -€543,713, the lowest from 2015 to 2025. It recovers the following year.
1 director resigningTaste Invest NV · Permanent representatives: Philip De Mulder and Inge Bruynooghe · Director discharge: Taste Invest NV · General meeting of 24-06-20225 points ▸
- General meeting, 24-06-2022
- Director resignation, Taste Invest NV
- Director discharge, Taste Invest NV
- Permanent representative, Philip De Mulder
- Permanent representative, Inge Bruynooghe
Annual accounts 2021 filed PDFmicro format · 9 days before the deadline
Capital increase of €21,359 to €257,219Capital after the increase: €257,219, 21,359 new shares · General meeting of 04-04-20223 points ▸
- General meeting, 04-04-2022
- Capital increase, €21,359
- Capital, €257,219, 257,219 shares
- The deed holds 3 more points.
2021
Appointment: Filip Tanghe (director)Permanent representative: Inge Bruynooghe · General meeting of 25-06-20213 points ▸
- General meeting, 25-06-2021
- Director appointment, Filip Tanghe
- Permanent representative, Inge Bruynooghe
- The deed holds 1 more point.
Annual accounts 2020 filed PDFmicro format · 31 days before the deadline
2020
Capital increase of €19,996 to €235,860Capital after the increase: €235,860, 19,996 new shares · General meeting of 30-09-20203 points ▸
- General meeting, 30-09-2020
- Capital increase, €19,996
- Capital, €235,860, 235,860 shares, mentioned twice in the deed
- The deed holds 6 more points.
Annual accounts 2019 filed PDFmicro format · 31 days before the deadline
Capital increaseGeneral meeting of 10-02-20201 point ▸
- General meeting, 10-02-2020
- The deed holds 5 more points.
2019
Liquidity more than 6 times current ratio 3.99 The current ratio rises from 0.61 to 3.99. Short-term debt falls from €214,745 to €132,730.
Equity above €500,000 equity €675,704 ▲517% Equity rises from €109,570 to €675,704.
2 directors appointed, 3 resignationsCapital from €166,000 to €183,614, 17,614 new shares · Capital after the increase: €215,864, 32,250 new shares · Change of role: MARTHA1996, from managing director to director · General meeting of 03-10-201918 points ▸
- General meeting, 03-10-2019
- Capital increase, €17,614
- Capital increase, €32,250
- Director resignation, DEPAUW Paul Richard Alfons Maria
- Director resignation, NEUROMEDICS
- Director resignation, MARTHA1996 (managing director)
- Permanent representative, DEPAUW Paul Richard Alfons Maria, mentioned twice in the deed
- Permanent representative, BRUYNOOGHE Inge Grietje Milo, mentioned twice in the deed
- Director resignation, BRUYNOOGHE Inge Grietje Milo
- Director discharge, DEPAUW Paul Richard Alfons Maria
- Director discharge, NEUROMEDICS
- Director discharge, MARTHA1996
- Director discharge, BRUYNOOGHE Inge Grietje Milo
- Director appointment, NEUROMEDICS
- Director appointment, MARTHA1996
- Director appointment, Taste Invest NV
- Permanent representative, DE MULDER Philip Frank Yvonne Raymond
- Capital, €215,864, 215,864 shares
- The deed holds 10 more points.
Annual accounts 2018 filed PDFmicro format · 23 days before the deadline
Registered office moved from Minderhout to TurnhoutNew registered office: Slachthuisstraat 120 Bus 8, 2300 Turnhout · Previous registered office: Bredaseweg 20, 2322 Minderhout · Permanent representative: Inge Bruynooghe · General meeting of 15-04-20193 points ▸
- General meeting, 15-04-2019
- Registered-office move, Slachthuisstraat 120 Bus 8, 2300 Turnhout
- Permanent representative, Inge Bruynooghe
2018
Back to profit net €5,842 The net result is €5,842, after 3 loss-making years.
2 directors appointedChange of role: Neuromedics BVBA, from managing director to director · Permanent representatives: Paul Depauw and Inge Bruynooghe · Appointments: Martha1996 BVBA (managing director) and Inge Bruynooghe · General meeting of 25-10-20187 points ▸
- General meeting, 25-10-2018
- Director resignation, Neuromedics BVBA (managing director)
- Permanent representative, Paul Depauw, mentioned twice in the deed
- Director appointment, Neuromedics BVBA
- Director appointment, Martha1996 BVBA (managing director)
- Permanent representative, Inge Bruynooghe
- Director appointment, Inge Bruynooghe
- The deed holds 1 more point.
Annual accounts 2017 filed PDFmicro format · 28 days before the deadline
2017
Annual accounts 2016 filed PDFmicro format · 31 days before the deadline
2016
Annual accounts 2015 filed PDFabbreviated format · 31 days before the deadline
Financial milestones sit on the financial year-end date, not the filing date.
Sources: Publications in the Belgian Official GazetteFilings with the National Bank
History
Ergotrics was incorporated on 8 December 2014.1 The registered office was moved to Turnhout in 2019.2 Between 2019 and 2022 the capital was increased 3 times, most recently to €257,219.345 Total assets rose from €324,316 in 2018 to €376,384 in 2025 and headcount from 1.9 full-time equivalents in 2019 to 1.8 in 2024.6